Despite Progress in TNBC, More Biomarkers Are Needed to Improve Outcomes

(MedPage Today) -- Although biomarker testing is playing a greater role in the management of triple-negative breast cancer (TNBC), treatment selection still relies on relatively few validated biomarkers.
Markers for Immunotherapy
Several new...